Pipeline Sanofi drops two more programmes in R&D clear-out PharmaphorumShortly after terminating one late-stage R D programme, Sanofi confirmed in its second-quarter update that two others are being scrapped.Read full story pharminent July 30, 2026 (Last updated: August 3, 2026) Pharmaphorum Shortly after terminating one late-stage R D programme, Sanofi confirmed in its second-quarter update that two others are being scrapped. Read full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: GSK Cambridge Move Signals Shift in Drug Scale-Up StrategyNext: Amgen’s Repatha Wins Positive CHMP Opinion for Preventing First Heart Attacks and Strokes Related Stories Pipeline Lundbeck preps for key bexicaserin data around year-end pharminent July 20, 2026 Pipeline AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist pharminent July 10, 2026 Pipeline Roche scraps two Ionis-partnered Huntington’s drugs pharminent July 9, 2026
